Celiac disease (CD), also known as gluten-sensitive enteropathy
|
|
- Mitchell Martin
- 5 years ago
- Views:
Transcription
1 CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5: Correlation of Duodenal Histology With Tissue Transglutaminase and Endomysial Antibody Levels in Pediatric Celiac Disease MATTHEW R. DONALDSON,* SEAN D. FIRTH, HOLLY WIMPEE,* KRISTIN M. LEIFERMAN,* JOHN J. ZONE,* WYATT HORSLEY,* MOLLY A. O GORMAN, W. DANIEL JACKSON, SUSAN L. NEUHAUSEN, CHRISTOPHER M. HULL,* and LINDA S. BOOK *Department of Dermatology and Division of Pediatric Gastroenterology, Department of Pediatrics, University of Utah, Salt Lake City, Utah; and Division of Epidemiology, Department of Medicine, University of California, Irvine, California Background & Aims: IgA antibodies against tissue transglutaminase (TTGA) and endomysium (EMA) are sensitive and specific markers for celiac disease (CD). Data correlating TTGA and EMA levels with degree of villous atrophy are limited. We compared duodenal histopathology in pediatric CD patients with TTGA and EMA serologies, symptoms, height, and weight. Methods: We identified 117 pediatric patients retrospectively who had serologic testing for IgA TTGA and IgA EMA and duodenal biopsies graded by modified Marsh criteria as 0 3c. Data were analyzed with Spearman rank correlation and multinomial logistic regression. Results: IgA TTGA (r.704, P <.001) and IgA EMA (r 0.740, P <.001) correlated with intestinal villous atrophy in pediatric CD patients by Spearman rank correlation. Similar correlations were found in a subset of 23 patients younger than 3 years of age. Multinomial logistic regression revealed increased probability of Marsh 3a or greater changes with increasing TTGA or EMA levels. Strongly positive antibody levels (TTGA >100 units or EMA titer >1:1280) were highly specific (>98%) for Marsh 3a or greater lesions. Among symptoms, abdominal distention and diarrhea were associated with abnormal histology. Conclusions: IgA TTGA and EMA levels correlate with duodenal villous atrophy in pediatric CD patients. IgA TTGA >100 or EMA >1:1280 were nearly always associated with CD histopathology. With further validation of this observation, strongly positive titers might be considered sufficient for diagnosis of pediatric patients at risk for CD. Symptoms, height, and weight are not reliable predictors of CD. Celiac disease (CD), also known as gluten-sensitive enteropathy (GSE), is an immune-mediated disease primarily affecting the small bowel. In genetically susceptible individuals, consumption of gluten triggers an inflammatory reaction with intraepithelial lymphocyte infiltration, crypt hyperplasia, and villous atrophy of the small bowel mucosa. 1 In children, these changes might cause malabsorption, diarrhea, abdominal distention, and abdominal pain, a broad range of non-classical findings, or be clinically silent. 2 4 Down syndrome, family history of GSE, and autoimmune disease such as type 1 diabetes mellitus (DM) and thyroiditis are associated with CD. 5,6 If left untreated, patients are at increased risk for gastrointestinal lymphoma and other malignancies. 7 Treatment with a glutenfree diet (GFD) achieves complete reversal of disease and eliminates increased risk of malignancy in most patients Estimates of disease prevalence vary, with Northern European or descendent populations having the highest rate at around 1%. 11,12 Data from Fasano et al 13,14 indicate that disease prevalence in average risk, predominantly white children in the United States is 1/320 and much higher in those at risk. Because of its variable, nonspecific, and often silent presentation, diagnosis of CD can be challenging. Characteristic histopathologic changes of the small bowel mucosa by biopsy are considered the gold standard of diagnosis. 5 Specimens are graded as 0 3c according to the modified Marsh criteria, with 3a or greater clearly consistent with CD, Marsh 2 possibly consistent, and Marsh 1 indicating nonspecific changes. 3 The gluten-triggered inflammatory response leads to activation of the humoral pathway and production of autoantibodies. 1,6 Assays to detect serum antibodies against tissue transglutaminase (TTGA), endomysium (EMA), and gliadin are used to screen patients for biopsy and follow response to treatment. 4,5 IgA anti-human recombinant TTGA (TTGA-HR) detected by enzyme-linked immunosorbent assay (ELISA) and IgA EMA seen on monkey esophagus (ME) or human umbilical cord (HUC) substrates by indirect immunofluorescence (IIF) are considered the most sensitive and specific serologic tests for CD. 15,16 In children, IgA TTGA-HR and IgA EMA-ME have reported diagnostic sensitivities and specificities exceeding 95%. 15,16 Patients with mild or intermediate mucosal changes, as might be observed in early CD, are frequently seronegative. This lowers the sensitivity of serology in practice It is well-established that increased EMA and TTGA in both children and adults correlate with abnormal small bowel histopathology. 10,17,19,21 25 Less data relating serologic levels to degree of villous atrophy are available, especially in the pediatric pop- Abbreviations used in this paper: CD, celiac disease; CI, confidence interval; DM, diabetes mellitus; EGD, esophagoduodenoscopy; ELISA, enzyme-linked immunosorbent assay; EMA-HUC, endomysial antibodies on human umbilical cord substrate; EMA-ME, endomysial antibodies on monkey esophagus substrate; GFD, gluten-free diet; GSE, gluten-sensitive enteropathy; IIF, indirect immunofluorescence; MLR, multinomial logistic regression; NASPGHAN, North American Society for Pediatric Gastroenterology Hepatology and Nutrition; ROC, receiver operating curve; TTGA-GP, tissue transglutaminase antibodies guinea pig; TTGA-HR, tissue transglutaminase antibodies human recombinant by the AGA Institute /07/$32.00 doi: /j.cgh
2 568 DONALDSON ET AL CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 5, No. 5 ulation. Tursi et al 19 studied 119 adults and observed that the prevalence of TTGA and the mean serum value were higher in CD patients with higher grade. In a study of 30 children, Hoffenberg et al 24 reported a correlation of r of TTGA titer and Marsh score. Information about the predictive value of clinical presentation is also limited. However, up to 1 in 33 patients referred to pediatric gastroenterology for symptoms or diseases associated with CD will have CD. 14 To investigate these relationships, we conducted a retrospective chart review of patients referred to a pediatric gastroenterology practice to be evaluated for CD. With multinomial logistic regression (MLR), we correlated histopathology from distal duodenal biopsies with IgA TTGA-HR and IgA EMA levels, height, weight, and symptoms at presentation. Materials and Methods Patients Charts of patients evaluated at a pediatric gastroenterology clinic at Primary Children s Medical Center (Salt Lake City, UT) for possible CD from were reviewed. Patients were referred for evaluation because of gastrointestinal or systemic complaints suggestive of CD, family history of GSE, recent diagnosis of type 1 DM or other associated autoimmune disease, or having Down syndrome. All patients were 18 years or younger, had no previous diagnosis of CD, and were not on a GFD. Subjects were included if duodenal biopsy with pathologic interpretation, serum, and clinical records were available. After undergoing history and physical examination by a boardcertified pediatric gastroenterologist, consent from responsible guardians was obtained for esophagogastroduodenoscopy (EGD). Before or at the time of biopsy, patients had blood drawn for serologic testing. Height and weight were obtained from clinic visits or procedure records at the time of biopsy. These were converted to approximate percentiles by using a standard growth curve for age and sex and adjusted for Down syndrome as appropriate. Symptoms of abdominal pain, abdominal distention, diarrhea, constipation, and vomiting were recorded as present or absent on the basis of pre-endoscopy clinic records. Esophagogastroduodenoscopy and Pathology Endoscopy was performed with a minimum of 4 forceps biopsies of the distal duodenum. 26 Specimens were oriented before embedding by an experienced technician. Fourmicrometer sections were stained with hematoxylin-eosin and examined by 1 of 4 board-certified pathologists experienced in the diagnosis of CD and without knowledge of serologic findings. A modified Marsh grade was assigned to each specimen: 0, normal; 1, increased intraepithelial lymphocytes; 2, increased intraepithelial lymphocytes plus hyperplastic crypts; 3a, partial villous atrophy; 3b, subtotal villous atrophy; 3c, complete villous atrophy. 27,28 If specimens demonstrated features of multiple grades, the higher grade was recorded. We used the recent North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) guidelines for assignment of a diagnosis of CD. 3 We considered all Marsh 3 lesions with positive serology consistent with a diagnosis of CD. Patients with Marsh 3 lesions and negative serology were considered to have CD if there were a clinical response to a GFD and no alternative diagnosis to account for the histologic abnormalities. Marsh 2 histology was considered CD in the context of positive serology. Marsh 1 lesions were considered nonspecific but possibly consistent with CD if serology was positive and symptoms responded to a GFD. Serology Serum IgA TTGA and EMA were measured by using commercial ELISA and IIF, respectively. Serum was obtained from whole blood by centrifugation at 3000 rpm for 10 minutes and frozen at 80 C with sodium azide. Semiquantitative detection of TTGA was performed by using the QUANTA Lite human recombinant TTGA IgA and IgG kits (INOVA Diagnostics, San Diego, CA). Per manufacturer recommendations, positivity was assigned at 20 units. IgA EMA were detected on cryostat sections of monkey esophagus by using fluorescein isothiocyanate conjugated anti-iga (Cappel, Cochranville, PA) as described previously. 29 Initial serum testing was performed at 1:5, 1:10, and 1:20 dilutions. When positive, IIF with serial 2-fold dilutions to 1:40,960 was carried out, and the limiting dilution, or end-point titer with positive staining, was recorded. Increased EMA were defined at 1:10 dilution or greater showing smooth muscle endomysial staining on monkey esophagus. Patients sera with positive staining at 1:5 but negative at 1:10 were considered negative. All slides were interpreted by a single, blinded, and experienced immunodermatologist (K.M.L.). Total serum IgA was determined by nephelometry by ARUP Laboratories (Salt Lake City, UT) or MININEPH human IgA kit (The Binding Site Ltd, Birmingham, UK). Per manufacturer s recommendations, patient serum was diluted to 1:11 and assayed on a mininephelometer. Serum IgA levels were recorded in g/dl. All values were referenced to manufacturer-published norms by age to evaluate for IgA deficiency. Patients with IgA deficiency were screened for IgG TTGA by using the INOVA kit as described above. 3,30,31 Statistics Data were analyzed by using Stata v9.2 (College Station, TX). For statistical analysis, EMA end-point titers were converted to an ordinal scale, with each incremental increase representing the next 2-fold dilution. Negative IIF at a 1:5 dilution was considered 0, positive (or indeterminate) staining at 1:5 was labeled a 1, positive staining at 1:10 was 2, positive at 1:20 was 3, and so on until 1:40,960 was 14. Spearman rank correlation was used to test the associations between Marsh scores and IgA EMA end-point titers and units of TTGA. Ninety-five percent confidence intervals (CIs) were calculated for Spearman rho. MLR was used to determine associations between histopathologic and serologic or clinical data. Logistic regression and post-estimation analyses of receiver operating curve (ROC), sensitivity, specificity, positive predictive values, and negative predictive values were used to evaluate cut points for TTGA as a predictor of Marsh scores. Results Patient Features A total of 117 pediatric patients who had clinical evaluation, serologic testing, and EGD with duodenal biopsy comprised our study group. We identified 80 patients with Marsh 1 or greater lesions and included 37 Marsh 0 patients evaluated during the same time period. Table 1 describes patient demo-
3 May 2007 DUODENAL HISTOLOGY, TTGA, AND EMA IN PEDIATRIC CD 569 Table 1. Patient Demographics, Comorbid Disease, and Symptoms Variable Marsh 0 Marsh 1 2 Marsh 3a c Number Male Female Age (y) (mean, SD) FHx of GSE 5 (14%) 3 (13%) 17 (30%) Comorbid disease Type 1 DM 1 (3%) 2 (8%) 14 (25%) Down syndrome 1 (3%) 0 4 (7%) Thyroiditis (4%) JRA 1 (3%) 0 0 Williams syndrome (2%) Autism/Asperger s 1 (3%) 2 (8%) 0 Symptom Diarrhea 18 (49%) 9 (38%) 37 (66%) Pain 20 (54%) 17 (71%) 36 (64%) Constipation 10 (27%) 7 (29%) 18 (32%) Vomiting 10 (27%) 6 (25%) 10 (18%) Distention 7 (19%) 7 (29%) 26 (46%) Height percentile 35% 28% 37% 31% 45% 28% (mean, SD) Weight percentile (mean, SD) 35% 33% 53% 35% 44% 32% Marsh 3b and most 3c patients had strongly positive IgA TTGA. Marsh 3a patients had the greatest variability with negative, positive, and strongly positive values represented (Table 2). Characteristics of Marsh 3 patients with negative serology are shown in Table 3. Of these 7 patients, 4 had confirmed CD by symptoms and response to a GFD, whereas 3 others had non- GSE disease. Analysis by MLR revealed a statistically higher probability of CD with increasing IgA TTGA-HR. Each unit of increase of TTGA-HR increased the risk of having a Marsh 3a, 3b, or 3c lesion by approximately 8%, 14%, or 10%, respectively. As shown in Table 4, the sensitivity of IgA TTGA-HR to predict Marsh 2 or higher or Marsh 3 lesions decreases as IgA TTGA-HR cut points increase. Conversely, as IgA TTGA-HR cut point increases, so do specificity and PPV. As shown in Figure 2, ROC analysis yields the highest area under the curve at the IgA TTGA-HR cut point of 40. As IgA TTGA-HR cut points increase above 40, the area under the ROC curves decreases. An IgA TTGA-HR cut point of 100 units yields 100% specificity and positive predictive value but 0% sensitivity. NOTE. Age, family history, associated disease, and symptom data were collected on all 117 patients, whereas 114 had for-age height and 115 had for-age weight percentiles recorded. SD, standard deviation; FHx of GSE, family history of GSE; JRA, juvenile rheumatoid arthritis. graphics, comorbid conditions, and symptoms by Marsh score. MLR analyses of associated conditions, symptoms, height, and weight related to Marsh grade were performed. Patients with type 1 DM had a significantly increased probability of Marsh 3b and 3c lesions (P.02). A family history of GSE was significantly associated with Marsh 3c lesions (P.05). There were no differences in height or weight percentiles for Marsh 3 patients compared with Marsh 0. Abdominal distention and diarrhea were statistically more likely in patients with Marsh 3 lesions, but there was no significant association with constipation, vomiting, or pain (data not shown). Immunoglobulin A Tissue Transglutaminase Antibodies, Human Recombinant and Marsh Grade One hundred seventeen patients had IgA TTGA-HR ELISA, with units ranging from as plotted in Figure 1A. Mean units for each Marsh group are shown in Table 2. IgA TTGA significantly correlated with Marsh grade (Spearman rho 0.704, P.001; 95% CI, ). Stratification of Marsh grades into quantitative TTGA groups (negative, 0 19 units; positive, units; strongly positive, 100 units) is also shown in Table 2. Seven patients with Marsh 0 1 lesions were TTGA-positive, and none had 100 units. Details regarding these patients are presented in Table 3. One Marsh 1 patient very likely had CD on the basis of response to a GFD, and 2 patients likely had latent CD on the basis of a strong family history. One of 5 Marsh 2 patients had positive serology (38 units). This patient likely had CD because his abdominal pain and bloating resolved and weight increased on a GFD. All Figure 1. Scatter plots of IgA TTGA and EMA by Marsh grade. (A) IgA TTGA-HR units are plotted on the y-axis against Marsh grade along the x-axis. (B) IgA EMA titers are plotted on the y-axis against Marsh grade on the x-axis.
4 570 DONALDSON ET AL CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 5, No. 5 Table 2. IgA TTGA and EMA by Marsh Group IgA TTGA-HR IgA EMA-ME Marsh N Mean units SD N, 20 U N, 20 to 100 U N, 100 U Median titer N, 1:10 N, 1:10 to 1:1280 N, 1: (95%) 2 (5%) (86%) 5 (14%) (74%) 5 (26%) (68%) 5 (26%) 1 (5%) (80%) 1 (20%) (80%) 1 (20%) 0 3a (23%) 8 (36%) 9 (41%) 1:320 6 (27%) 6 (27%) 10 (45%) 3b (100%) 1: (6%) 15 (94%) 3c (17%) 2 (11%) 13 (72%) 1: (11%) 1 (6%) 15 (83%) SD, standard deviation. Immunoglobulin A Endomysial Antibodies and Marsh Grade One hundred seventeen patients had IgA EMA-ME with titers ranging from negative to positive at 1:40,960 as plotted in Figure 1B. Median titers are shown in Table 2. IgA EMA significantly correlated with Marsh grade (Spearman rho 0.740, P.001; 95% CI, ). Patients from each Marsh group were quantitatively stratified by EMA titer (negative, 1:10; positive, 1:10 1:640; strongly positive, 1:1280) in Table 2. Table 3 describes Marsh 0 1 patients who were IgA EMA positive. One had a reproducible, atypical immunofluorescence pattern. Five of six Marsh 1 patients with increased EMA were also IgA TTGA positive. The Marsh 2 patient who responded to a GFD described above was both IgA EMA and TTGA positive. Nearly all Marsh 3b and 3c patients were strongly positive for EMA. Again, Marsh 3a patients showed the broadest distribution among negative, positive, and strongly positive groups. Analysis by MLR revealed a significantly higher probability of Marsh 3 lesions with increasing IgA EMA titers. EMA positivity at each successive 2-fold dilution increased the risk of having a Marsh 3a, 3b, or 3c lesion by approximately 54%, 130%, or 93%, respectively. Sensitivity of IgA EMA with a positive cut off of 1:10 was 73% for Marsh 3a, 100% for 3b, and 89% for 3c lesions. At a higher cut off of 1:1280, sensitivity was comparable for Marsh 3b (94%) or 3c (83%) lesions and decreased for 3a (45%). The specificity of the higher cut off for Marsh 3 lesions was 98%. As shown in Table 3, Marsh 3 patients negative for IgA EMA showed a strong concordance with IgA TTGA. Effect of Age on Histopathologic Association With Immunoglobulin A Tissue Transglutaminase Antibodies and Endomysial Antibodies Twenty-three of 117 patients were younger than 3 years of age at the time of evaluation. Spearman rank correlation comparing Marsh grade with serology yielded coefficients of for TTGA (P.001; 95% CI, ) and for Table 3. Patients With Discordant Serology and Histology Patient Age (y) Marsh IgA EMA-ME (titer) IgA TTGA (U) GI Sx Background GFD response Dx Biopsy, serology :5 34 No FHx Latent CD :5 22 Yes No CD :80 3 Yes Down None No CD :320 3 Yes No CD :10 19 Yes EE : No FHx Latent CD :20 3 Yes EG :80 32 Yes EE : Yes FHx Latent CD : Yes Improved CD :80 35 Yes Unknown :80 40 Yes DM Refused Unknown : No FHx Latent CD Biopsy, serology 1 2 3a 1:5 4 Yes Improved CD a 1:5 3 Yes IBD 3 2 3a 1:5 11 Yes Improved CD a 1:5 3 Yes Improved CD 5 4 3a 1:5 3 No None EG 6 2 3c 1:5 4 Yes IBD 7 4 3c 1:5 4 Yes Improved CD NOTE. Titers, presence of symptoms, response to GFD where known, and final diagnosis are indicated. For diagnosis, non-cd disease is specified, or a diagnosis of CD, no CD, latent CD, or unknown was established according to guidelines described in the Methods. GI Sx, gastrointestinal symptoms; Dx, diagnosis; FHx, family history; Down, Down syndrome; EE, eosinophilic esophagitis; EG, eosinophilic gastroenteritis.
5 May 2007 DUODENAL HISTOLOGY, TTGA, AND EMA IN PEDIATRIC CD 571 Table 4. Sensitivity, Specificity, Positive and Negative Predictive Values, ROC Area for IgATTGA-HR Cut Points for Marsh Scores of 2 or Greater and 3 Marsh score IgATTGA-HR units Sensitivity Specificity PPV NPV ROC area % 77.1% 78.1% 88.7% 83.2% % 88.5% 87.3% 87.1% 87.1% % 90.2% 88.7% 85.9% 87.1% % 98.4% 97.9% 85.7% 90.3% % 78.6% 81.3% 83.0% 81.9% % 89.3% 89.1% 80.7% 84.8% % 91.1% 90.6% 79.7% 84.9% % 98.2% 97.9% 78.6% 86.8% PPV, positive predictive value; NPV, negative predictive value. EMA (P.001; 95% CI, ) in this subset. Patients younger than 3 years of age represented all Marsh grades, with serologies as follows: 10 of 11 Marsh 0 2 patients were seronegative for both IgA EMA and TTGA, whereas one Marsh 0 patient was IgA EMA positive and TTGA negative; all eight Marsh 3b or 3c patients were seropositive by both assays. One Marsh 3a patient was TTGA-positive (63 units) and negative for EMA. Two Marsh 3 patients were both EMA- and TTG-negative but met clinical criteria for CD (Table 3). Immunoglobulin A Deficiency Five patients were found to be IgA-deficient for age. These included two Marsh 0, one Marsh 2, one Marsh 3a, and one Marsh 3c patients. No IgA-deficient patients negative for IgA TTGA were positive for IgG TTGA. Although both Marsh 0 patients were negative for IgG and IgA TTGA, one was IgA EMA positive at a titer of 1:20. The Marsh 2 patient was negative for IgG and IgA TTGA and indeterminate for IgA EMA at 1:5. The Marsh 3a IgA-deficient patient was negative for IgA and IgG TTGA and IgA EMA. The only IgA-deficient Marsh 3c patient was positive by all 3 assays. Discussion According to recently published guidelines, serologic testing is of primary importance in screening for CD. 3 We found that increasing IgA TTGA-HR units or EMA-ME titers correlated with a higher probability of partial to complete villous atrophy in 117 pediatric patients. A similar correlation was present in children younger than 3 years, a population in whom the reliability of serology has been questioned. These findings mirror previously reported correlations between IgA TTGA-GP (guinea pig) titers and Marsh grade found in 119 adult and 30 pediatric patients. 19,24 In another study of 47 patients ranging from 3 73 years of age, increasing TTGA-GP levels and EMA-HUC titers were associated with more severe villous atrophy.25 The difficulty in making generalizations from these studies lies in lack of assay standardization. With IIF to detect EMA, results might vary with substrate type (ME vs HUC), source, and observer. 3,32 The IgA TTGA-GP ELISA used by Tursi et al has a slightly lower sensitivity and specificity compared with IgA TTGA-HR, with TTGA-HR now recognized as the standard. 16,33 However, more than one commercial IgA TTGA-HR ELISA is available. Our findings indicate both a concordance between IgA TTGA-HR and IgA EMA and a significant correlation between each assay and Marsh grade in pediatric patients. Establishing a correlation between quantitative serology and small bowel histopathology has considerable clinical utility. When considering arbitrarily chosen cutoffs of IgA TTGA 100 units or EMA 1:1280, we observed 100% and 98% specificity for Marsh 3a or higher lesions, respectively. A modified diagnostic algorithm suggesting strongly positive IgA TTGA-GP ( 100 units) be considered diagnostic without biopsy was recently proposed. 34 The authors of this proposal found that 48 of 49 patients (98%) with IgA TTGA 100 units had Marsh 2 or greater lesions. Given the sample size, risk of misdiagnosis, and morbidity of the GFD, others disagree. 35 TTGA-GP 100 units has been reported in 2 patients with normal duodenal biopsies and a third with CD histolopathology but no response to a GFD. 36 In addition, patients with Crohn s disease, ulcerative colitis, primary biliary cirrhosis, and autoimmune hepatitis can have TTGA, although markedly increased levels have not been reported. 37,38 These latter studies suggest that non-cd patients positive for TTGA are EMA-negative. In our sample of 117 patients, IgA TTGA 100 was present in 38 patients and uniformly indicated Marsh 3a or greater lesions on biopsy. In contrast to Barker et al, 34 we used a TTGA-HR assay and considered only Marsh 3a and greater lesions as positive. A similar phenomenon was seen with strongly positive IgA EMA-ME because 40 of 41 patients with a titer 1:1280 had at least Marsh 3a changes on biopsy. One Marsh 1 patient was strongly IgA EMA positive at a titer of 1:2560, IgA TTGA Figure 2. ROC. Depicting maximum area under the curve for Marsh 3 histology at cut point of TTGA-HR 40 units.
6 572 DONALDSON ET AL CLINICAL GASTROENTEROLOGY AND HEPATOLOGY Vol. 5, No. 5 positive with 68 units, and had gastrointestinal complaints suggestive of early CD. Small bowel changes in CD can be patchy. 39,40 In rare cases of strongly positive IgA EMA or TTGA with Marsh 2 or lesser lesions, higher grade pathology might have been missed by sampling error. As demonstrated by our patients with discordant biopsies and serologies in Table 3, the diagnosis of CD requires clinical judgment and expertise. Despite serologic, histopathologic, and clinical data, the diagnosis might remain unclear in some patients. Negative serologies occurred in approximately 15% of patients with Marsh 3 lesions. Four of 7 of these were assigned a diagnosis of CD. These patients were generally younger, with 6 of 7 younger than 4 years, and IgA deficiency was present in one. Intermediate Marsh grades and partial villous atrophy have been associated with negative serology previously. 17,18,41 In one study, Dickey et al42 found that one fifth of IgA EMA negative patients had Marsh 3a or greater lesions. Others have reported sensitivities and specificities of IgA TTGA-HR or IgA EMA-ME that were lower than those typically quoted. 17,43 Villous atrophy in the context of negative serology could result from non-gse disease. False-positive biopsies might also result from overinterpretation of specimens or poor specimen orientation. We found that Marsh 2 changes in our pediatric population were uncommon, occurring in only 5 of 117 individuals. Only one of these was assigned a diagnosis of CD. Our findings are consistent with NASPGHAN guidelines indicating that Marsh 2 changes are less specific for CD, and such patients require positive serology and clinical judgment to make the diagnosis. 3 Positive serologic tests with Marsh 0 and 1 changes are also unlikely to indicate CD. Nearly 10% of our patients were in this category. Four asymptomatic patients could be reasonably classified as having latent CD because of strong family histories of GSE. Only one Marsh 1 patient with positive serology convincingly responded to a GFD and was considered to have CD. Guidelines indicate serum IgA should be performed in all patients screened for IgA-class TTGA or EMA. 3 In our population, 2 patients with histologic changes of CD were IgA-deficient. The first, graded as a Marsh 3c on biopsy, had increased IgA EMA, IgA TTGA, and IgG TTGA. The second was Marsh 3a by biopsy and was seronegative for IgG and IgA-class TTGA as well as IgA EMA. Currently, CD is thought to present with severe growth delay infrequently. 44 MLR suggested height or weight for age was not useful to predict Marsh lesions in our patients. Our findings are consistent with those of Hoffenberg et al, 45 who did not observe a difference in weight or height for age in TTGA-positive children. Although bloating and diarrhea were associated with high Marsh grades, we generally found that symptoms or growth parameters cannot reliably predict CD. 17,24 Our data show that IgA TTGA and EMA levels correlate with severity of histologic changes in a population at high risk for pediatric CD. The positive predictive value of serology becomes more favorable and clinically useful in populations with a high prevalence of CD, such as patients with Down syndrome, DM, or a family history of GSE. We found that greatly increased antibody levels predict villous atrophy on biopsy. However, we approach modifying the current diagnostic algorithm with caution. 3 More studies are needed to confirm that markedly elevated IgA TTGA ( 100 units) or IgA EMA ( 1:1280) rarely occurs in the absence of CD. Until then, duodenal biopsy remains the gold standard for confirmation of the diagnosis. When circumstances preclude small intestinal biopsy in patients with strongly positive serology, it might be appropriate and safe to treat directly with a GFD. References 1. Kagnoff MF. Overview and pathogenesis of celiac disease. Gastroenterology 2005;128:S10 S Fasano A. Clinical presentation of celiac disease in the pediatric population. Gastroenterology 2005;128:S68 S Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40: Dewar DH, Ciclitira PJ. Clinical features and diagnosis of celiac disease. Gastroenterology 2005;128:S19 S Green PH, Jabri B. Celiac disease. Annu Rev Med 2006;57: Alaedini A, Green PH. Narrative review: celiac disease understanding a complex autoimmune disorder. Ann Intern Med 2005; 142: Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005; 128:S79 S Pink IJ, Creamer B. Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1967;1: Collin P, Reunala T, Pukkala E, et al. Coeliac disease associated disorders and survival. Gut 1994;35: Sategna-Guidetti C, Pulitano R, Grosso S, et al. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993;17: Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 2005;128:S47 S Dube C, Rostom A, Sy R, et al. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology 2005;128:S57 S Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163: Hill I, Fasano A, Schwartz R, et al. The prevalence of celiac disease in at-risk groups of children in the United States. J Pediatr 2000;136: Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? do sensitivity and specificity vary in different populations? Gastroenterology 2005;128:S25 S Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128:S38 S Abrams JA, Diamond B, Rotterdam H, et al. Seronegative celiac disease: increased prevalence with lesser degrees of villous atrophy. Dig Dis Sci 2004;49: Tursi A, Brandimarte G, Giorgetti G, et al. Low prevalence of antigliadin and anti-endomysium antibodies in subclinical/silent celiac disease. Am J Gastroenterol 2001;96: Tursi A, Brandimarte G, Giorgetti GM. Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease. J Clin Gastroenterol 2003;36: Tursi A, Brandimarte G. The symptomatic and histologic response to a gluten-free diet in patients with borderline enteropathy. J Clin Gastroenterol 2003;36: Szaflarska-Szczepanik A. Assessment of correlation between the presence of antiendomysial antibodies and small intestine mucosal villous atrophy in the diagnostics of celiac disease. Med Sci Monit 2002;8:CR185 CR188.
7 May 2007 DUODENAL HISTOLOGY, TTGA, AND EMA IN PEDIATRIC CD Ozgenc F, Aksu G, Aydogdu S, et al. Association between antiendomysial antibody and total intestinal villous atrophy in children with coeliac disease. J Postgrad Med 2003;49: Demir H, Yuce A, Kocak N, et al. Celiac disease in Turkish children: presentation of 104 cases. Pediatr Int 2000;42: Hoffenberg EJ, Bao F, Eisenbarth GS, et al. Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr 2000;137: Kotze LM, Utiyama SR, Nisihara RM, et al. IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease. Pathology 2003; 35: Dandalides SM, Carey WD, Petras R, et al. Endoscopic small bowel mucosal biopsy: a controlled trial evaluating forceps size and biopsy location in the diagnosis of normal and abnormal mucosal architecture. Gastrointest Endosc 1989;35: Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11: Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity ( celiac sprue ). Gastroenterology 1992;102: Unsworth DJ. ACP broadsheet no 149: September 1996 serological diagnosis of gluten sensitive enteropathy. J Clin Pathol 1996;49: Dahlbom I, Olsson M, Forooz NK, et al. Immunoglobulin G (IgG) anti-tissue transglutaminase antibodies used as markers for IgAdeficient celiac disease patients. Clin Diagn Lab Immunol 2005; 12: Korponay-Szabo IR, Dahlbom I, Laurila K, et al. Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 2003;52: Russo PA, Chartrand LJ, Seidman E. Comparative analysis of serologic screening tests for the initial diagnosis of celiac disease. Pediatrics 1999;104: Wong RC, Wilson RJ, Steele RH, et al. A comparison of 13 guinea pig and human anti-tissue transglutaminase antibody ELISA kits. J Clin Pathol 2002;55: Barker CC, Mitton C, Jevon G, et al. Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 2005;115: Rashid M. Diagnosing celiac disease with a positive serological test and without an intestinal biopsy. Pediatrics 2005;116: Freeman HJ. Strongly positive tissue transglutaminase antibody assays without celiac disease. Can J Gastroenterol 2004;18: Clemente MG, Musu MP, Frau F, et al. Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr 2002;34: Di Tola M, Sabbatella L, Anania MC, et al. Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med 2004;42: Bonamico M, Mariani P, Thanasi E, et al. Patchy villous atrophy of the duodenum in childhood celiac disease. J Pediatr Gastroenterol Nutr 2004;38: Ravelli A, Bolognini S, Gambarotti M, et al. Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy. Am J Gastroenterol 2005;100: Rostami K, Kerckhaert J, Tiemessen R, et al. Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol 1999; 94: Dickey W, Hughes DF, McMillan SA. Reliance on serum endomysial antibody testing underestimates the true prevalence of coeliac disease by one fifth. Scand J Gastroenterol 2000;35: Rostami K, Kerckhaert JP, Tiemessen R, et al. The relationship between anti-endomysium antibodies and villous atrophy in coeliac disease using both monkey and human substrate. Eur J Gastroenterol Hepatol 1999;11: Catassi C, Fasano A. Celiac disease as a cause of growth retardation in childhood. Curr Opin Pediatr 2004;16: Hoffenberg EJ, Emery LM, Barriga KJ, et al. Clinical features of children with screening-identified evidence of celiac disease. Pediatrics 2004;113: Address requests for reprints to: Linda Book, MD, Professor of Pediatrics, Chief, Pediatric Gastroenterology, University of Utah, 100 N Medical Dr, Salt Lake City, Utah linda.book@ intermountainmail.org; fax: (801) Supported by NIH Grant DK50678 (S.N.) and Dermatology Foundation Career Development Grant (C.H.). The authors would like to thank all patients for participating in this study. They would also like to thank Marjorie Campbell in the Immunodermatology Laboratory at the University of Utah for technical assistance and personnel in medical records at Primary Children s Medical Center.
Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions
Intern Emerg Med (2012) 7:337 342 DOI 10.1007/s11739-011-0585-8 IM - ORIGINAL Serology in adults with celiac disease: limited accuracy in patients with mild histological lesions Anna Licata Maria Cappello
More informationMP Madhu 1, Prachis Ashdhir 1, Garima Sharma 2, Gyan Prakash Rai 1, Rupesh Kumar Pokharna 1, Dilip Ramrakhiani 2 ABSTRACT
Tropical Gastroenterology 2017;38(2):102-107 Original Article Correlation of serum levels of IgA antitissue transglutaminase (IgA ttg) with the histological severity in celiac disease MP Madhu 1, Prachis
More informationPediatric Typical Vs. Atypical Celiac Disease: Correlation of Duodenal Histology With Tissue Transglutaminase Levels
Original Article Elmer Press Pediatric Typical Vs. Atypical Celiac Disease: Correlation of Duodenal Histology With Tissue Transglutaminase Levels Aleksandra Boskovic a, b, Ivana Kitic a, Dragan Prokic
More informationOHTAC Recommendation
OHTAC Recommendation Clinical Utility of Serologic Testing for Celiac Disease in Asymptomatic Patients Presented to the Ontario Health Technology Advisory Committee in May and June 2011 July 2011 Background
More informationThe presentation of celiac disease in 220 Turkish children
The Turkish Journal of Pediatrics 2010; 52: 239-244 Original The presentation of celiac disease in 220 Turkish children Necati Balamtekin, Nuray Uslu, Gökhan Baysoy, Yusuf Usta, Hülya Demir, İnci Nur Saltık-Temizel,
More informationLaboratory Methods for Diagnosing Celiac Disease. Vijay Kumar, PhD, FACB IMMCO Diagnostics, Inc. Buffalo, NY
Laboratory Methods for Diagnosing Celiac Disease Vijay Kumar, PhD, FACB IMMCO Diagnostics, Inc. Buffalo, NY Prevalence of Celiac Disease Group With Symptoms Adults Children Associated Symptoms Chronic
More informationCeliac Disease. Marian Rewers, MD, PhD. Professor & Clinical Director Barbara Davis Center for Diabetes University of Colorado School of Medicine
Celiac Disease Marian Rewers, MD, PhD Professor & Clinical Director Barbara Davis Center for Diabetes University of Colorado School of Medicine No relevant financial relationships with any commercial interests
More informationDefinition. Celiac disease is an immune-mediated enteropathy caused by a permanent sensitivity to gluten in genetically susceptible individuals.
Definition 1 Definition Celiac disease is an immune-mediated enteropathy caused by a permanent sensitivity to gluten in genetically susceptible individuals. It occurs in symptomatic subjects with gastrointestinal
More informationCoeliac Disease: Diagnosis and clinical features
Coeliac Disease: Diagnosis and clinical features Australasian Gastrointestinal Pathology Society AGM 28 Oct 2016 Dr. Hooi Ee Gastroenterologist, Sir Charles Gairdner Hospital Coeliac disease Greek: koiliakos
More informationCeliac Disease and IgA Deficiency: Complications of Serological Testing Approaches Encountered in the Clinic
Clinical Chemistry 54:7 1203 1209 (2008) Evidence-Based Laboratory Medicine and Test Utilization Celiac Disease and IgA Deficiency: Complications of Serological Testing Approaches Encountered in the Clinic
More informationPredictors of Clinical Response to Gluten-Free Diet in Patients Diagnosed With Diarrhea-Predominant Irritable Bowel Syndrome
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:844 850 Predictors of Clinical Response to Gluten-Free Diet in Patients Diagnosed With Diarrhea-Predominant Irritable Bowel Syndrome ULRICH WAHNSCHAFFE,*
More informationIgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease
Pathology (2003) 35, pp. 56 60 IMMUNOLOGY IgA class anti-endomysial and anti-tissue transglutaminase antibodies in relation to duodenal mucosa changes in coeliac disease LORETE MARIA DA SILVA KOTZE *,
More informationHistologic Follow-up of People With Celiac Disease on a Gluten-Free Diet Slow and Incomplete Recovery
Anatomic Pathology / HISTOLOGIC FOLLOW-UP OF PEOPLE WITH CELIAC DISEASE ON A GLUTEN-FREE DIET Histologic Follow-up of People With Celiac Disease on a Gluten-Free Diet Slow and Incomplete Recovery Peter
More informationPreface and outline of the thesis
Preface Celiac disease (CD) is characterized by a chronic immune reaction in the small intestine to the gluten proteins that are present in a (Western) daily diet, derived from wheat, barley and rye. It
More informationCoeliac Disease Bible Class Questions and Answers
Coeliac Disease Bible Class Questions and Answers Jan Hendrik Niess What is the definition of coeliac disease? Coeliac disease is an immune reaction to gluten (wheat, barely, rye) in an genetic predisposed
More informationAge-Related Patterns in Clinical Presentations and Gluten- Related Issues Among Children and Adolescents With Celiac Disease
Age-Related Patterns in Clinical Presentations and Gluten- Related Issues Among Children and Adolescents With Celiac Disease The Harvard community has made this article openly available. Please share how
More informationKristin Kenrick, FRNZCGP Department of General Practice and Rural Health Dunedin School of Medicine (Supported by Coeliac New Zealand)
Kristin Kenrick, FRNZCGP Department of General Practice and Rural Health Dunedin School of Medicine (Supported by Coeliac New Zealand) That you will go away thinking about your practice population, and
More informationORIGINAL ARTICLE Histopathological features of coeliac disease in a sample of Sudanese patients
Malaysian J Pathol 2016; 38(3) : 267 272 ORIGINAL ARTICLE Histopathological features of coeliac disease in a sample of Sudanese patients MA Noha MOKHTAR, SO MEKKI, HMY MUDAWI*, SH SULAIMAN**, MA TAHIR,
More informationIs Intestinal Biopsy Always Needed for Diagnosis of Celiac Disease?
THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 98, No. 6, 2003 2003 by Am. Coll. of Gastroenterology ISSN 0002-9270/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0002-9270(03)00229-6 Is Intestinal Biopsy
More informationCLINICOPATHOLOGICAL STUDY OF AN IRAQI PATIENTS GROUP SUSPECTED TO HAVE COELIAC DIASEASE
Innovative Journal of Medical and Health Science 2: 5 Sep Oct (2012) 98 103. Contents lists available at www.innovativejournal.in INNOVATIVE JOURNAL OF MEDICAL AND HEALTH SCIENCE Journal homepage: http://www.innovativejournal.in/index.php/ijmhs
More informationDiagnostic score model for childhood coeliac disease. Submitted
4 Diagnostic score model for childhood coeliac disease Hogen Esch CE Funke genaamd Küpper B Driessen SRC Dbijou N van Huis M Verhage J von Blomberg BME Putter H Mearin ML These authors contributed equally
More informationCoeliac Disease in 2016: A shared care between GPs and gastroenterologists. Dr Roslyn Vongsuvanh
Coeliac Disease in 2016: A shared care between GPs and gastroenterologists Dr Roslyn Vongsuvanh Ms JM 23 year old female Born in Australia. Parents from Lebanon. Engineering student Presents with lethargy
More informationLevel 2. Non Responsive Celiac Disease KEY POINTS:
Level 2 Non Responsive Celiac Disease KEY POINTS: Celiac Disease (CD) is an autoimmune condition triggered by ingestion of gluten leading to intestinal damage and a variety of clinical manifestations.
More informationClinical Study Frequency of Celiac Disease in Patients with Hypothyroidism
Thyroid Research Volume 2012, Article ID 201538, 6 pages doi:10.1155/2012/201538 Clinical Study Frequency of Celiac Disease in Patients with Hypothyroidism Mojtaba Mehrdad, 1 Fariborz Mansour-Ghanaei,
More informationCeliac Disease: An Assessment of Subjective Variation and Diagnostic Reproducibility of the Various Classification Systems
: C Microbiology and Pathology Volume 15 Issue 1 Version 1.0 Year 2015 Type: Double Blind Peer Reviewed International Research Journal Publisher: Global Journals Inc. (USA) Online ISSN: 2249-4618 & Print
More informationIs a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant?
424 ORIGINAL ARTICLE Is a raised intraepithelial lymphocyte count with normal duodenal villous architecture clinically relevant? S Mahadeva, J I Wyatt, P D Howdle... See end of article for authors affiliations...
More informationCeliac Disease (CD) Diagnosis and Whom to Screen
Celiac Disease (CD) Diagnosis and Whom to Screen Maureen Leonard MD Fellow, MassGeneral Hospital for Children Twitter-Follow me @CeliacDoc Follow the MGH Celiac Center @CeliacResearch Conflicts of Interest
More informationA Practical Approach to Small Bowel Biopsies: All that flattens is not sprue
A Practical Approach to Small Bowel Biopsies: All that flattens is not sprue UCSF Liver and Gastrointestinal Pathology Update Sept. 4, 2009 How to Go Wrong When Evaluating Small Bowel Biopsies, Based on
More informationResearch Article Routine Duodenal Biopsies in the Absence of Endoscopic Markers of Celiac Disease Are Not Useful: An Observational Study
ISRN Endoscopy Volume 2013, Article ID 623936, 5 pages http://dx.doi.org/10.5402/2013/623936 Research Article Routine Duodenal Biopsies in the Absence of Endoscopic Markers of Celiac Disease Are Not Useful:
More informationIII,II,I III.
,II,I e-mail: shahraki2002@yahoo.com I II (Cript) X 2 IgA II a I c b IV IgA AESKULISA,GERMANY J Babol Univ Med Sci; 11(4); Oct-Nov 2009 Clinical and Laboratory Findings of Celiac ; T. Shahraki, et al Mahjoub
More informationCoeliac Disease in Children and Adolescents with Type 1 Diabetes Mellitus
Clin Pediatr Endocrinol 1998; 7(2), 125-129 Copyright 1998 by The Japanese Society for Pediatric Endocrinology Coeliac Disease in Children and Adolescents with Type 1 Diabetes Mellitus Francesco Chiarelli,
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Coeliac Disease
Southern Derbyshire Shared Care Pathology Guidelines Coeliac Disease Purpose of Guideline When and how to investigate patients for Coeliac Disease What the results mean When and how to refer patients Monitoring
More informationAutoimmune diseases in Turner syndrome
International Congress Series 1298 (2006) 42 48 www.ics-elsevier.com Autoimmune diseases in Turner syndrome L. Mazzanti a,, R.W. Naeraa b a Department of Pediatrics, University of Bologna, S. Orsola-Malpighi
More informationRefractory celiac disease (RCD) KASSEM BARADA LEBANESE SOCIETY OF GASTROENTEROLOGY NOVEMBER, 2014
Refractory celiac disease (RCD) KASSEM BARADA LEBANESE SOCIETY OF GASTROENTEROLOGY NOVEMBER, 2014 Case scenario (1) A 49 year woman presents with intermittent watery diarrhea and bloating of two years
More informationTips for Managing Celiac Disease. Robert Berger MD FRCPC Gastroenterology New Brunswick Internal Medicine Update April 22, 2016
Tips for Managing Celiac Disease Robert Berger MD FRCPC Gastroenterology New Brunswick Internal Medicine Update April 22, 2016 Disclosures None relevant to this presentation Objectives Briefly review the
More informationSelf transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method
Alimentary Pharmacology & Therapeutics Self transglutaminase-based rapid coeliac disease antibody detection by a lateral flow method T. RAIVIO*, K. KAUKINEN, à,é. NEMES, K.LAURILA*,P.COLLIN, à,j.b.kovács**,
More informationThe Turkish Journal of Pediatrics 2014; 56:
The Turkish Journal of Pediatrics 2014; 56: 347353 Original Accuracy of HLADQ genotyping in combination with IgA antitissue transglutaminase serology and a scoring system for the diagnosis of celiac disease
More informationSheila E. Crowe, MD, FRCPC, FACP, FACG, AGAF Department of Medicine University of California, San Diego
Severe and Emergency Presentations of Celiac Disease Sheila E. Crowe, MD, FRCPC, FACP, FACG, AGAF Department of Medicine University of California, San Diego Case Presentation (1) 63 year old male transferred
More informationAnti-tissue transglutaminase antibodies (IgA and IgG) in both Crohn's disease and autoimmune diabetes
1130-0108/2011/103/9/453-457 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright 2011 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol. 103. N. 9, pp. 453-457, 2011 ORIGINAL PAPERS Anti-tissue transglutaminase
More informationImproving basic skills in celiac-like disease diagnosis: a case report
Corleto et al. BMC Gastroenterology (2018) 18:162 https://doi.org/10.1186/s12876-018-0894-8 CASE REPORT Open Access Improving basic skills in celiac-like disease diagnosis: a case report Vito Domenico
More informationCeliac Disease. M. Nedim Ince, MD University of Iowa Hospital
Celiac Disease M. Nedim Ince, MD University of Iowa Hospital Contents Cases Definition Etiopathogenesis Pathology Diagnosis Management of the disease Management of complications Case I Five year old boy
More informationArchive of SID. Original Article
Original Article Frequency of Celiac Disease in Children with Beta Thalassemia major Honar N MD 1, Kamali S MD 2, Karimi M MD 3* 1. Assistant Professor of pediatric gastroenterologist, Department of gastroenterology,
More informationMædica - a Journal of Clinical Medicine
MAEDICA a Journal of Clinical Medicine 2016; 11(6): 109-114 Mædica - a Journal of Clinical Medicine ORIGINAL PAPER Celiac Disease Phenotype in Clinically Diagnosed Romanian Adults and Children Vasile BALABAN
More informationDr Kristin Kenrick. Senior Lecturer Dunedin School of Medicine
Dr Kristin Kenrick Senior Lecturer Dunedin School of Medicine Kristin Kenrick, FRNZCGP Department of General Practice and Rural Health Dunedin School of Medicine (Supported by Coeliac New Zealand) Because
More informationSeronegative celiac disease: where is the specific setting?
Gastroenterology and Hepatology From Bed to Bench. 2015 RIGLD, Research Institute for Gastroenterology and Liver Diseases REVIEW ARTICLE Seronegative celiac disease: where is the specific setting? Enzo
More informationThe diagnosis of celiac disease (CD) still relies on the demonstration
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2007;5:838 843 Comparison of the Interobserver Reproducibility With Different Histologic Criteria Used in Celiac Disease GINO ROBERTO CORAZZA,* VINCENZO VILLANACCI,
More informationARTICLE IN PRESS. Michael N. Marsh DM, DSc, FRCP University Department of Pathology, Ankara School of Medicine, Ankara, Turkey
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 Best Practice & Research Clinical Gastroenterology Vol. xx,
More informationInternal Medicine, d Departments of Thoracic Surgery, e Pathology and f Gastroenterology Unit, University of Palermo, Palermo, Italy
Original article 1 Antiendomysium antibodies assay in the culture medium of intestinal mucosa: an accurate method for celiac disease diagnosis Antonio Carroccio a, Giuseppe Iacono b, Lidia Di Prima c,
More informationThe Changing Face of Celiac Disease. John Snyder, MD
The Changing Face of Celiac Disease John Snyder, MD Special Thanks Blair and Steve Raber, founders of the Children s National Celiac Disease Program Rhonda and Peter Resnick, for providing a generous gift
More informationIgA anti-actin antibodies ELISA in coeliac disease: A multicentre study
Digestive and Liver Disease 39 (2007) 818 823 Alimentary Tract IgA anti-actin antibodies ELISA in coeliac disease: A multicentre study A. Carroccio a,, I. Brusca b, G. Iacono c, M.G. Alessio d, A. Sonzogni
More informationEndomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits
1746 COELIAC DISEASE Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits T T Salmi, P Collin, I R Korponay-Szabó, K Laurila, J Partanen, H Huhtala,
More informationUNDERDIAGNOSIS OF COELIAC DISEASE MODULE 1
UNDERDIAGNOSIS OF COELIAC DISEASE MODULE 1 UNDERDIAGNOSIS OF COELIAC DISEASE MODULE 1 UNDERDIAGNOSIS OF COELIAC DISEASE Written by: Melissa Wilson BSc (Hons) SRD Coeliac Disease Resource Centre Presented
More informationWendy Miller 1, Andrew S Day 2,* *Corresponding author:
International Journal of Celiac Disease, 2014, Vol. 2, No. 4, 126-130 Available online at http://pubs.sciepub.com/ijcd/2/4/8 Science and Education Publishing DOI:10.12691/ijcd-2-4-8 A Retrospective Application
More informationMucosal Recovery and Mortality in Adults with Celiac Disease After Treatment With a Gluten-free Diet
From The American Journal of Gastroenterology Mucosal Recovery and Mortality in Adults with Celiac Disease After Treatment With a Gluten-free Diet Alberto Rubio-Tapia MD; Mussarat W Rahim MBBS; Jacalyn
More informationGLUTEN RELATED DISORDERS
Celiac disease Overcoming clinical challenges Disclosures Scientific Advisory Board Cellimune, Immunsant, Innovate Pharmaceuticals Peter HR Green MD Phyllis and Ivan Seidenberg Professor of Medicine Director,
More informationFactors associated with number of duodenal samples obtained in suspected celiac disease
Factors associated with number of duodenal samples obtained in suspected celiac disease Authors Leonid Shamban 1, Serge Sorser 2,StanNaydin 3,BenjaminLebwohl 4,MousaShukr 5, Charlotte Wiemann 5,Daniel
More informationWhat is your diagnosis? a. Lymphocytic colitis. b. Collagenous colitis. c. Common variable immunodeficiency (CVID) associated colitis
Case History A 24 year old male presented with fatigue, fever, watery diarrhea, and a cough with sputum production for the past three weeks. His past medical history was significant for recurrent bouts
More informationCLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Mar. 2000, p Vol. 7, No. 2
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Mar. 2000, p. 192 196 Vol. 7, No. 2 1071-412X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Immunoglobulin A (IgA) Deficiency
More informationNATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE. Coeliac disease: recognition, assessment and management of coeliac disease
Appendix B: NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Coeliac disease: recognition, assessment and management of coeliac disease 1.1 Short title Coeliac disease 2 The remit
More informationACG Clinical Guideline: Diagnosis and Management of Celiac Disease
ACG Clinical Guideline: Diagnosis and Management of Celiac Disease Alberto Rubio-Tapia, MD 1, Ivor D. Hill, MD 2, Ciarán P. Kelly, MD 3, Audrey H. Calderwood, MD 4 and Joseph A. Murray, MD 1 1 Division
More informationFood Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence
Food Choices and Alternative Techniques in Management of IBS: Fad Versus Evidence Maria Vazquez Roque, MD, MSc Assistant Professor Gastroenterology and Hepatology 2010 MFMER slide-1 Objectives Gluten-free
More informationJason Chan. School of Epidemiology, Public Health and Preventive Medicine. Faculty of Medicine. University of Ottawa
The Burden of Biopsy-Proven Pediatric Celiac Disease in Ontario, Canada: Derivation of Health Administrative Data Algorithms and Determination of Health Services Utilization Jason Chan Thesis submitted
More informationSmall bowel diseases. Györgyi Műzes 2015/16-I. Semmelweis University, 2nd Dept. of Medicine
Small bowel diseases Györgyi Műzes 2015/16-I. Semmelweis University, 2nd Dept. of Medicine Celiac disease (revised definition!) a systemic autoimmune disorder Occurs in genetically susceptible individuals
More informationEvaluation of HLA-DQ2/DQ8 genotype in patients with celiac disease hospitalised in 2012 at the Department of Paediatrics
Original paper Evaluation of HLA-DQ/DQ8 genotype in patients with celiac disease hospitalised in 1 at the Department of Paediatrics Dorota A. Szałowska-Woźniak 1, Leokadia Bąk-Romaniszyn,3, Agnieszka Cywińska-Bernas
More informationCopyright ESPGHAN and NASPGHAN. All rights reserved.
JPGN Journal of Pediatric Gastroenterology and Nutrition Publish Ahead of Print DOI: 10.1097/MPG.0b013e31821a23d0 ESPGHAN guidelines for the diagnosis of coeliac disease in children and adolescents. An
More informationa Tampere University Hospital and University of Tampere, Finland, b University Received 4 February 2004 Revised 20 April 2004 Accepted 3 June 2004
Original article 85 Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac : a biopsy-proven European multicentre study Pekka Collin a, Katri Kaukinen a,
More informationCrohn s disease (CD) is a chronic inflammatory disease of
ORIGINAL ARTICLE High Prevalence of Celiac Disease Among Patients Affected by Crohn s Disease Antonio Tursi, MD,* Gian Marco Giorgetti, MD, Giovanni Brandimarte, MD, and Walter Elisei, MD Background: Recent
More informationGPMP and TCA Coeliac disease
MP and TCA Coeliac disease ITEM: prepares MP (721) REVIEWS MP (732) prepared TCA (723) REVIEW TCA (732) PATIENT DETAILS: DETAILS: DATE PREPARED: Does a current management plan or Team care arrangement
More informationEffects of age of diagnosis and dietary compliance on growth parameters of patients with celiac disease
Original article Arch Argent Pediatr 2018;116(4):248-255 / 248 Effects of age of diagnosis and dietary compliance on growth parameters of patients with celiac disease Atakan Comba, M.D. a, Gönül Çaltepe,
More informationCoeliac Patients Are Undiagnosed at Routine Upper Endoscopy
Coeliac Patients Are Undiagnosed at Routine Upper Endoscopy Kathryn Robson 1, Michelle Alizart 1, Jarad Martin 2, Robyn Nagel 1,3 * 1 Toowoomba Gastroenterology Clinic, Medici Medical Centre, Toowoomba,
More informationCELIAC DISEASE WHAT S THE LATEST? Peter HR Green MD
CELIAC DISEASE WHAT S THE LATEST? Peter HR Green MD pg11@columbia.edu CELIAC DISEASE Common Underdiagnosed Biopsy is the gold standard for diagnosis CLINICAL FEATURES Dig Dis Sci. 2014 EJGH, Sontig 2013
More informationThe high prevalence and clinical heterogeneity of celiac
Article Annals of Internal Medicine Accuracy of Serologic Tests and HLA-DQ Typing for Diagnosing Muhammed Hadithi, MD; B. Mary E. von Blomberg, PhD; J. Bart A. Crusius, PhD; Elisabeth Bloemena, MD, PhD;
More informationCOSA NON È CELIACHIA ( uno sguardo obliquo )
COSA NON È CELIACHIA ( uno sguardo obliquo ) Gino Roberto Corazza I Clinica Medica Fondazione IRCCS Policlinico San Matteo Università di Pavia HOLY PAPERS OF COELIAC DISEASE Gut 2012 Gut 2014 JPGN 2012
More informationKids Like to Break the Rules: Gastrointestinal Pathology in Children
Kids Like to Break the Rules: Gastrointestinal Pathology in Children Jeffrey Goldsmith MD Director of Surgical Pathology, Beth Israel Deaconess Medical Center; Consultant in Gastrointestinal Pathology,
More informationResearch Article Narrow Band Imaging with Magnification Endoscopy for Celiac Disease: Results from a Prospective, Single-Center Study
Diagnostic and Therapeutic Endoscopy Volume 2013, Article ID 580526, 6 pages http://dx.doi.org/10.1155/2013/580526 Research Article Narrow Band Imaging with Magnification Endoscopy for Celiac Disease:
More informationDiagnostic Technology: Point-of-care testing for coeliac disease
Horizon Scan Report 0023 Date: 29 August 2012 Diagnostic Technology: Point-of-care for coeliac disease Clinical Questions: (1) In patients presenting to primary care with suspected coeliac disease (CD),
More informationAnti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease
Alimentary Pharmacology & Therapeutics Anti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease C. R. DIPPER, S. MAITRA, R. THOMAS, C. A. LAMB, A. P. C. MCLEAN-TOOKE, R.WARD, D.
More informationThe current diagnostic criteria for celiac disease require. Diagnosing Mild Enteropathy Celiac Disease: A Randomized, Controlled Clinical Study
GASTROENTEROLOGY 2009;136:816 823 Diagnosing Mild Enteropathy Celiac Disease: A Randomized, Controlled Clinical Study KALLE KURPPA,* PEKKA COLLIN,, MERVI VILJAMAA,* KATRI HAIMILA, PÄIVI SAAVALAINEN, JUKKA
More informationChapter 12: Training in Pathology. DDSEP Chapter 13: Question 19
DDSEP Chapter 13: Question 19 A 70 year-old male with a history of celiac disease diagnosed in his forties reports abdominal pain, dark stools, and 20-pound weight loss. He reports complete compliance
More informationRole of Histology to Measure Clinical Benefit and Appropriate Timing of Assessment
Role of Histology to Measure Clinical Benefit and Appropriate Timing of Assessment Benjamin Lebwohl MD, MS Herbert Irving Assistant Professor of Medicine and Epidemiology Celiac Disease Center Columbia
More informationType 1 diabetic adults should be screened for coeliac autoimmunity. We read with great interest the article by Joshi et al.
Type 1 diabetic adults should be screened for coeliac autoimmunity TO THE EDITOR Dear Sir: We read with great interest the article by Joshi et al. in the June 2014 issue of Arab Journal of Gastroenterology.(1)
More informationResearch Article Frequency of Celiac Disease in Adult Patients with Typical or Atypical Malabsorption Symptoms in Isfahan, Iran
Gastroenterology Research and Practice Volume 2012, Article ID 106965, 6 pages doi:10.1155/2012/106965 Research Article Frequency of Celiac Disease in Adult Patients with Typical or Atypical Malabsorption
More informationPrevalence of Celiac Disease in type 1 Diabetes Mellitus in children and adolescents attending Children Welfare Teaching Hospital
Original Article Prevalence of Celiac Disease in type 1 Diabetes Mellitus in children and adolescents attending Children Welfare Teaching Hospital * Huda Y. Matloub* Batool A. Gh.Yassin** MBChB, CABP MBChB.
More informationDoes gluten free diet have more implications than treatment of celiac disease?
Gastroenterology and Hepatology From Bed to Bench. 2015 RIGLD, Research Institute for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Does gluten free diet have more implications than treatment of
More informationDepartment of Pediatrics, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
pissn: 2234-8646 eissn: 2234-8840 https://doi.org/10.5223/pghn.2017.20.4.222 Pediatr Gastroenterol Hepatol Nutr 2017 December 20(4):222-226 Original Article PGHN Celiac Disease in South Jordan Eyad Altamimi
More informationThe Frequency of Celiac Disease in Children with Functional Abdominal Pain
ARC Journal of Pediatrics Volume 4, Issue 2, 2018, PP 1-5 ISSN 2455-5711 http://dx.doi.org/10.20431/2455-5711.0402001 www.arcjournals.org The Frequency of Celiac Disease in Children with Functional Abdominal
More informationCost-effectiveness analysis of screening for celiac disease in the adult population Shamir R, Hernell O, Leshno M
Cost-effectiveness analysis of screening for celiac disease in the adult population Shamir R, Hernell O, Leshno M Record Status This is a critical abstract of an economic evaluation that meets the criteria
More informationAssessing the prevalence of coeliac disease in patients with intellectual disabilities
Assessing the prevalence of coeliac disease in patients with intellectual disabilities Abstract Previous studies have suggested a high prevalence of coeliac disease in patients with intellectual disabilities
More informationSupplemental Table 1: Moderate and severe definitions of Celiac Disease Symptom Diary
Supplemental Table 1: Moderate and severe definitions of Celiac Disease Symptom Diary symptoms CDSD Symptom Diarrhea Constipation Abdominal Pain Bloating Nausea Tiredness Moderate Once or twice between
More informationElevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency
567 COELIAC DISEASE Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency I R Korponay-Szabó, I Dahlbom, K Laurila, S Koskinen,
More informationROME AND PERUGIA, ITALY
Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease ANTONIO PICARELLI, MARCO DI
More information(Leven and Tomer, 3002). González et al, 3002). Reffubat et al, 7002). (ISPAD) 3000
The association between type 1 diabetes mellitus and autoimmune thyroid diseases has long been documented. Both are organ specific T- cell mediated disease, and have a similar pathogenesis, which involves
More informationThe role of flow cytometry in celiac disease screening using human leukocyte antigen in adult patients with type 1 diabetes mellitus
ORIGINAL ARTICLE Annals of Gastroenterology (2017) 30, 1-7 The role of flow cytometry in celiac disease screening using human leukocyte antigen in adult patients with type 1 diabetes mellitus Miren Vicuña
More informationClinical Utility of Serologic Testing for Celiac Disease in Asymptomatic Patients
Ontario Health Technology Assessment Series 2011; Vol. 11, No. 3 Clinical Utility of Serologic Testing for Celiac Disease in Asymptomatic Patients An Evidence-Based Analysis July 2011 Medical Advisory
More informationTissue transglutaminase levels above 100 U/mL and celiac disease: A prospective study
Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v18.i32.4399 World J Gastroenterol 2012 August 28; 18(32): 4399-4403 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2012 Baishideng.
More informationA Genomewide Screen in a Four-Generation Dutch Family with Celiac Disease: Evidence for Linkage to Chromosomes 6 and 9
American Journal of Gastroenterology ISSN 0002-9270 C 2004 by Am. Coll. of Gastroenterology doi: 10.1111/j.1572-0241.2004.04072.x Published by Blackwell Publishing A Genomewide Screen in a Four-Generation
More informationGastroenterology. Certification Examination Blueprint. Purpose of the exam
Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist
More informationRedefining the intraepithelial lymphocytes threshold to diagnose gluten sensitivity in patients with architecturally normal duodenal histology
Alimentary Pharmacology and Therapeutics Redefining the intraepithelial lymphocytes threshold to diagnose gluten sensitivity in patients with architecturally normal duodenal histology S. Pellegrino*,,
More informationCeliac disease (CD) is a permanent inflammatory
Celiac disease in 87 children with typical and atypical symptoms in Black Sea region of Turkey Gönül Dinler, Erdal Atalay, Ayhan Gazi Kalaycı Samsun, Turkey 282 Background: Celiac disease presents with
More information2017 NEEDS ASSESSMENT SURVEY
2017 NEEDS ASSESSMENT SURVEY Quick Overview: Educational Topic Findings The online 2017 Needs Assessment survey was programmed through SurveyMonkey and a personalized request to complete the questionnaire
More information